Search results for: 'tubes nmr 10 mm'
- Did you mean
- tube nmr 10 mm
-
-
13C, 15N Calbindin in Solution
CCN10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
13C, 15N Calbindin in Solution
CCN10014P5
3 - 6 weeks• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N -
13C, 15N SH3 in Solution
CCN10054P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N -
13C, 15N SH3 in Solution
CCN10054P5
3 - 6 weeks• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6k Da
• Labeling: 13C, 15N -
13C, 15N, D Ubiquitin in Solution
CCND10064P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Ubiquitin in Solution
CCND10064P5
3 - 6 weeks• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D -
15N Calbindin in Solution
CN10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
15N Microcrystalline GB1
CN10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 15N -
15N Microcrystalline GB1
CN10033P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 15N -
15N GB1 in Solution
CN10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 15N -
15N GB1 in Solution
CN10034P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 15N -
15N MBP in Solution
CN10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 15N -
15N MBP in Solution
CN10044P5
3 - 6 weeks• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 15N -
13C, 15N Microcrystalline GB1
CCN10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N Microcrystalline GB1
CCN10033P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N GB1 in Solution
CCN10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N GB1 in Solution
CCN10034P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N -
13C, 15N MBP in Solution
CCN10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N -
13C, 15N MBP in Solution
CCN10044P5
3 - 6 weeks• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N -
13C, 15N, D Calbindin in Solution
CCND10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Calbindin in Solution
CCND10014P5
3 - 6 weeks• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D SH3 in Solution
CCND10054P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D SH3 in Solution
CCND10054P5
3 - 6 weeks• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 k Da
• Labeling: 13C, 15N, D -
-
13C, 15N, D Microcrystalline GB1
CCND10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D Microcrystalline GB1
CCND10033P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D GB1 in Solution
CCND10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D GB1 in Solution
CCND10034P5
3 - 6 weeks• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N, D -
13C, 15N, D MBP in Solution
CCND10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N, D -
13C, 15N, D MBP in Solution
CCND10044P5
3 - 6 weeks• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N, D -
150 mL Suprasil Nitrogen Dewar Flask
WG-850-Q$1,428.202-4 weeksFor Micro-Now, Radio-Pan and Agilent instruments -
-
-
Precision Thin Wall Quartz Sleeve, 5.5 x 6.0 x 58.6 mm
NE-295-5A$111.504 - 6 weeksFor Bruker Late Model Probes -
Precision Thin Wall Quartz Sleeve, 5.8 x 6.1 x 54.5 mm
NE-295-5B$157.504 - 6 weeksFor Bruker Dual Flow Probes -
Precision Thin Wall Quartz Sleeve, 5.8 x 6.1 x 64 mm
NE-295-V-5$157.504 - 6 weeksFor Varian Probes -
-
n-dodecyl b-D-maltopyranoside-d25 (DDM-d25)
CD5066P025$2,860.004 - 8 weeks• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 % -
-
-
-
-
-
-
unlabeled fMLF
C10073P100
3 - 6 weeks• 100 mg
• Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Crystallized -
unlabeled fMLF
C10073P50
3 - 6 weeks• 50 mg
• Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Crystallized -
unlabeled fMLF
C10073P500
3 - 6 weeks• 500 mg
• Unlabeled N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Crystallized -
13C fMLF
CC10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C
• Crystallized -
13C fMLF
CC10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C
• Crystallized -
15N fMLF
CN10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 15N
• Crystallized -
15N fMLF
CN10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 15N
• Crystallized -
13C, 15N fMLF
CCN10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N
• Crystallized -
13C, 15N fMLF
CCN10073P5
3 - 6 weeks• 5 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N
• Crystallized -
13C, 15N fMLF
CCN10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N
• Crystallized -
13C, 15N, D fMLF
CCND10073P20
3 - 6 weeks• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• Crystallized -
13C, 15N, D fMLF
CCND10073P5
3 - 6 weeks• 5 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• Crystallized -
13C, 15N, D fMLF
CCND10073P50
3 - 6 weeks• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• Crystallized